SYNTAX II: The Path to Modern PCI

The SYNTAX II Clinical Trial1 is a landmark study that explores the impact of systematically doing the best possible Percutaneous Coronary Intervention (PCI). This includes gathering and assessing more patient information, adopting state-of-the-art techniques, and integrating proven best practices. SYNTAX II, supported by an ecosystem of clinical evidence, provides a blueprint for a holistic, individualized approach to PCI that can lead to significant reductions in negative clinical endpoints and improvements in procedure outcomes. The main takeaway? PCI patients can experience excellent, CABG-like outcomes out to five years and beyond.

 
Statistically significant improvement in long-term outcomes, Reduction in definite ST, High quality outcomes in complex cases
 

 
SYNTAX II circles
 
 
 
 

 

Every Patient, Any Challenge


The field of PCI is continuously evolving. Boston Scientific can guide you on the journey to modern PCI - understanding, integrating, and applying clinical data and best practices that, combined, enable you to personalize treatment and provide the best possible outcomes for your patients.

 

 

Treat every case with total confidence by leveraging the latest data.

Get exclusive product updates, training and educational opportunities, and more. 

Fill out a quick form and one of our sales representatives will be in touch. 
 
Top